inFocus
Emerging Chemotherapeutic Options for Breast Cancer
From data presented at:
the 38th Annual Meeting of the
American Society of Clinical Oncology (ASCO)
May 18-21, 2002/Orlando, Florida
Guest Editor
Jean-Marc A. Nabholtz, MD, MS
Professor, Department of Medicine
University of California at Los Angeles (UCLA) School of Medicine
Director, Cancer Therapy Development Program
UCLA Jonsson Comprehensive Cancer Center
Los Angeles, California
Chairman and Founder
Breast Cancer International Research Group (BCIRG)
Medical Review
Vinod Puri, MD, FRCP (C)
Department of Gastroenterology and Internal Medicine
William Osler Health Center
Ontario, Canada
copyright© 2002, PeerView Press